New Delhi: It was reported on Dec 14 that the Serum Institute of India (SII) planned to launch the Novavax (NVAX.O) COVID-19 vaccine for kids in six months. SII CEO, Adar Poonawalla said that the global vaccine reserves were outrunning the absorption capacity of many countries. According to reports, Novavaxsho has shown good results in trials in children aged three and older.
